EUVIMEDEUVIMED entdecken
Crossref

Pituitary Stalk Interruption Syndrome in Adulthood: Diagnostic Recognition, Clinical Spectrum, and Long-Term Follow-Up

Zeynep Elüstü Belten iD, Bahar Atasoy, Özge Şahin Kimyon, Selin Çelik, Didem Acarer Bugün iD, İlkay Çakır, Hamide Pişkinpaşa iD, Meral Mert, Sema Çiftçi iD

Hormone and Metabolic Research · 09.11.2026

DOI: 10.1055/a-2989-4273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hormone and Metabolic Research, online erschienen am 09.11.2026. Verfasst von Zeynep Elüstü Belten und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Health Sciences, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Department of Endocrinology and Metabolism, Turkey, Istanbul. Die Arbeit nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pituitary stalk interruption syndrome is usually diagnosed during childhood, and data on outcomes in adulthood are limited. This retrospective, single-center study evaluated the diagnostic history, endocrine phenotype, and clinical outcomes of 14 adults with radiologically confirmed pituitary stalk interruption syndrome. The cohort comprised eight men and six women, with a mean age of 28.8±6.4 years and a mean documented follow-up at our center of 5.6±3.2 years. Hypopituitarism was diagnosed during childhood in 12 patients and during adulthood in 2 patients. Thirteen patients had deficiencies of all four anterior pituitary hormone axes, whereas one patient had growth hormone and gonadotropic deficiencies with preserved corticotropic and thyrotropic functions. In six patients diagnosed during childhood, pituitary stalk interruption syndrome was recognized only after later reassessment of pituitary imaging. Eleven patients received growth hormone treatment during childhood, and 13 of 14 patients reached their calculated target height. Metabolic dysfunction–associated steatotic liver disease and dyslipidemia were each present in 10 patients. Four patients had bone mineral density below the expected range for age. One female patient achieved a live birth following in vitro fertilization. In this real-world cohort, the skeletal and metabolic findings observed despite generally favorable growth outcomes support the need for lifelong endocrine follow-up.

Autor:innen und Institutionen

  • University of Health Sciences, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Department of Endocrinology and Metabolism, Turkey, Istanbul.
  • University of Health Sciences, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Department of Radiology, Turkey, Istanbul.
  • University of Health Sciences, Pituitary Disorders Research Center, Turkey, Istanbul.

ORCID-Profile: Zeynep Elüstü Belten, Didem Acarer Bugün, Hamide Pişkinpaşa, Sema Çiftçi

Zitieren

APA

Elüstü Belten, Z., Atasoy, B., Şahin Kimyon, Ö., Çelik, S., Acarer Bugün, D., Çakır, İ., Pişkinpaşa, H., Mert, M., & Çiftçi, S. (2026). Pituitary Stalk Interruption Syndrome in Adulthood: Diagnostic Recognition, Clinical Spectrum, and Long-Term Follow-Up. Hormone and Metabolic Research. https://doi.org/10.1055/a-2989-4273

Vancouver

Elüstü Belten Z, Atasoy B, Şahin Kimyon Ö, Çelik S, Acarer Bugün D, Çakır İ, et al. Pituitary Stalk Interruption Syndrome in Adulthood: Diagnostic Recognition, Clinical Spectrum, and Long-Term Follow-Up. Hormone and Metabolic Research. 2026. doi:10.1055/a-2989-4273

BibTeX
@article{ElstBelten2026,
  author = {Elüstü Belten, Zeynep and Atasoy, Bahar and Şahin Kimyon, Özge and Çelik, Selin and Acarer Bugün, Didem and Çakır, İlkay and Pişkinpaşa, Hamide and Mert, Meral and Çiftçi, Sema},
  title = {Pituitary Stalk Interruption Syndrome in Adulthood: Diagnostic Recognition, Clinical Spectrum, and Long-Term Follow-Up},
  journal = {Hormone and Metabolic Research},
  year = {2026},
  doi = {10.1055/a-2989-4273}
}
Kostenlos starten →